Search Results for "poverty guidelines"
Displaying 41 - 60 of 75 results. 20 results shown per page. Page 3 of 4.
Neighborhoods and Health: Building Evidence for Local Policy
Publication Date
Contents Site-Specific Analyses Cross-Site Analysis: The Changing Urban Context Cross-Site Analysis: Health Trends and Study Hypotheses Conclusions
NTP — Nickel: HHS Response to RFC, October 24, 2003
Publication Date
October 24, 2003 Mr. Neil J. King Wilmer, Cutler & Pickering 2445 M. Street, N.W. Washington, D.C. 20037-1420 Dear Mr. King:
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, November 19,2012
Publication Date
November 19,2012 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
NTP — Naphthalene: HHS Response to Rfr
Publication Date
Date: November 2, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council Re: Naphthalene Information Quality Act Request for Reconsideration submitted February 18, 2005 Dear Ms. Price:
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, January 17,2013
Publication Date
January 17,2013 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier,
NTP — Atrazine: Request for Reconsideration (RFR)
Publication Date
Date: June 24, 2005 Associate Director for Communications Office of the Director National Institutes of Health INFORMATION QUALITY APPEAL(By Hand Delivery) Dear Sir or Madam: By this document, we appeal the denial of our request for correction (“RFC”) under the Information Quality Act (“IQA”).1
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, July 16, 2013
Publication Date
July 16, 2013 Mr. Paul D. HagemeierVice President- Regulatory ComplianceChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Mr. Hagemeier:
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, September 13, 2013
Publication Date
September 13, 2013 Mr. Paul D. HagemeierVice President- Regulatory ComplianceChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Mr. Hagemeier:
NTP — Anthraquinone Report: NTP Response
Publication Date
From: Chemical Products Corporation Date: March 14,2005 To: Associate Director for Communications, Office of the Director, National Institutes of Health Subject: Request For Correction of NTP TR-494 Abstract Dear Madam or Sir;
NTP — Anthraquinone Report: Letter to NTP
Publication Date
From: Chemical Products Corporation Date: March 14,2005 To: Associate Director for Communications, Office of the Director, National Institutes of Health Subject: Request For Correction of NTP TR-494 Abstract Dear Madam or Sir;
FDA — Mercury in Fish: HHS Response to Rfr
Publication Date
Date: May 16 2005 From: Food and Drug Administration College Park, MD 20740 To: Jane Houlihan, Vice President for Research Arianne Callendar, Legal Counsel Environmental Working Group 1436 U Street, N.W. Suite 100 Washington, D.C. 20009 Dear Ms. Houlihan and Ms. Callendar:
NTP — Styrene Background Document: Request for Correction (RFC)
Publication Date
Styrene Information and Research Center (SIRC)1300 Wilson Boulevard, Suite 1200, Arlington Virginia 22209(phone and fax redacted) Website www.styrene.org October 26, 2009
NTP — Anthraquinone Report: HHS Response to Rfc
Publication Date
July 16, 2004 Mr. Jerry A. Cook Technical Director Chemical Products Corporation P.O. Box 2470 Cartersville, Georgia 30120-1692 Re: Request for Correction submitted February 6, 2004 Dear Mr. Cook:
NTP — Anthraquinone Report: Request for Reconsideration (RFR)
Publication Date
July 29, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 1 Center Drive Bethesda, Maryland 20892 Subject: Information Quality Appeal - Request for Reconsideration Dear Madam or Sir;
NTP — Atrazine: Request for Correction(RFC)
Publication Date
July 16, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 9000 Rockville Pike Bethesda, MD 20892 Re: Information Quality Act Request for Correction of Information: Atrazine Dear Sir or Madam:
NTP–Anthraquinone Study: HHS Response to RFC
Publication Date
Date: APR 21 2005 To: Mr. Ken Ballinger, Vice President Airepel 3521 Silverside Road, Concord Plaza - Quillen Building, Wilmington, Delaware 19810 Re: Request for Correction dated January 18,2005 Dear Mr. Ballinger:
NTP — Report on Carcinogens: Request for Correction (RFC)
Publication Date
June 28, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 9000 Rockville Pike Bethesda, MD 20892 Re: Information Quality Act Request for Correction of Information: RoC Procedures Dear Sir or Madam:
FDA — Genasense: HHS Response to Rfc
Publication Date
NDA 21-649 Ms. Nancy L. Buc, Ms. Deborah Livornese Buc & Beardsley 919 Eighteenth Street N.W. Washington, D.C. 20006-5503. Dear Ms. Buc and Livornese:
CDC/ATSDR — Mixtures Guidance: Request for Correction (RFC)
Publication Date
Request for Correction of Atsdr Mixtures Guidance Document Date: Submitted electronically on December 5,2005